An assessment of appropriate advanced imaging utilization for Medicare fee-for-service beneficiaries, being conducted on behalf of the Centers for Medicare and Medicaid Services (CMS), is now underway.

GE Healthcare today announced that it has received 510(k) clearance from the Food and Drug Administration (FDA) for its SenoBright1 Contrast Enhanced Spectral Mammography (CESM) technology.

The “super-committee” charged by President Obama with slashing $1.2 trillion to $1.5 trillion from the U.S. budget deficit over the next 10 years should not accomplish part of this task by cutting $3.5 billion from the $15 billion Prevention and Public Health Fund.

An aging global population, growing need for early disease diagnosis, an increase in the number of diagnostic centers, and development of advanced imaging technologies and radiopharmaceuticals will boost the global market for bioimaging technologies to a projected $37.4 billion by the year 2017.

RamSoft, a Toronto, Ontario-based provider of RIS, PACS, and teleradiology solutions, yesterday announced that its PowerServer 5.1 solution has achieved 2011/2012 Complete EHR* ONC-ATCB Certification. The latter designates that the software is capable of supporting providers with Stage 1 Meaningful Use measures required to qualify for funding under

In health care, people are quite literally the most valuable asset. For most practices, the cost of staff dwarfs nearly all other expenditures.

The U.S. Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) announced Friday that they will now review products simultaneously under a new parallel review program.

In a setback for the breast density awareness movement, California Gov. Jerry Brown has vetoed legislation that would have required women whose mammograms revealed dense breast tissue to be informed of this fact.